These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 29274572)
1. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening. Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572 [TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2 Musoev A; Numonov S; You Z; Gao H Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858 [TBL] [Abstract][Full Text] [Related]
3. Identification of a Novel Scaffold for Inhibition of Dipeptidyl Peptidase-4. Mishra A; Cross M; Hofmann A; Coster MJ; Karim A; Sattar A J Comput Biol; 2019 Dec; 26(12):1470-1486. PubMed ID: 31390221 [TBL] [Abstract][Full Text] [Related]
4. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation. Meduru H; Wang YT; Tsai JJ; Chen YC Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951 [TBL] [Abstract][Full Text] [Related]
5. Discovery of tight-binding competitive inhibitors of dipeptidyl peptidase IV. Pascual Alonso I; Valiente PA; Valdés-Tresanco ME; Arrebola Y; Almeida García F; Díaz L; García G; Guirola O; Pastor D; Bergado G; Sánchez B; Charli JL Int J Biol Macromol; 2022 Jan; 196():120-130. PubMed ID: 34920066 [TBL] [Abstract][Full Text] [Related]
6. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays. Guasch L; Ojeda MJ; González-Abuín N; Sala E; Cereto-Massagué A; Mulero M; Valls C; Pinent M; Ardévol A; Garcia-Vallvé S; Pujadas G PLoS One; 2012; 7(9):e44971. PubMed ID: 22984596 [TBL] [Abstract][Full Text] [Related]
7. Virtual screening of dipeptidyl peptidase-4 inhibitors using quantitative structure-activity relationship-based artificial intelligence and molecular docking of hit compounds. Hermansyah O; Bustamam A; Yanuar A Comput Biol Chem; 2021 Dec; 95():107597. PubMed ID: 34800858 [TBL] [Abstract][Full Text] [Related]
8. DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of Kim BR; Kim HY; Choi I; Kim JB; Jin CH; Han AR Molecules; 2018 Aug; 23(8):. PubMed ID: 30103438 [TBL] [Abstract][Full Text] [Related]
10. 3D QSAR and docking study of gliptin derivatives as DPP-IV inhibitors. Agrawal R; Jain P; Dikshit SN; Bahare RS Comb Chem High Throughput Screen; 2013 May; 16(4):249-73. PubMed ID: 23305140 [TBL] [Abstract][Full Text] [Related]
11. Combined Ligand-Based and Structure-Based Virtual Screening Approach for Identification of New Dipeptidyl Peptidase 4 Inhibitors. Upadhyay J; Gajjar A; Suhagia BN Curr Drug Discov Technol; 2019; 16(4):426-436. PubMed ID: 30255759 [TBL] [Abstract][Full Text] [Related]
12. Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening. Al-Masri IM; Mohammad MK; Taha MO ChemMedChem; 2008 Nov; 3(11):1763-79. PubMed ID: 18989859 [TBL] [Abstract][Full Text] [Related]
13. Structure-based virtual screening of dipeptidyl peptidase 4 inhibitors and their in vitro analysis. Rahman SU; Ali HS; Jafari B; Zaib S; Hameed A; Al-Kahraman YMSA; Langer P; Iqbal J Comput Biol Chem; 2021 Apr; 91():107326. PubMed ID: 32739275 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors. Wu D; Jin F; Lu W; Zhu J; Li C; Wang W; Tang Y; Jiang H; Huang J; Liu G; Li J Chem Biol Drug Des; 2012 Jun; 79(6):897-906. PubMed ID: 22381062 [TBL] [Abstract][Full Text] [Related]
15. In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors. Nongonierma AB; Mooney C; Shields DC; FitzGerald RJ Peptides; 2014 Jul; 57():43-51. PubMed ID: 24793774 [TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl peptidase IV Inhibitory activity of Terminalia arjuna attributes to its cardioprotective effects in experimental diabetes: In silico, in vitro and in vivo analyses. Mohanty IR; Borde M; Kumar C S; Maheshwari U Phytomedicine; 2019 Apr; 57():158-165. PubMed ID: 30668318 [TBL] [Abstract][Full Text] [Related]